Savara Investor Lunch

Anassa Taverna, September 13, 2017

Join management of Savara Pharmaceuticals [SVRA] on September 13 in NYC for an informal lunch.

Anassa Taverna
200 E 60th St, New York, NY 10022
Starts at 12 PM

Savara Pharmaceuticals is a newly public company (NASDAQ: SVRA) focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions.

Products

  • Molgradex – Inhaled nebulized GM-CSF to treat Pulmonary Alveolar Proteinosis (PAP)
  • AeroVanc – Inhaled dry-powder Vancomycin to treat chronic methicillin-resistant Staphylococcus aureus (MRSA) pulmonary infection in Cystic Fibrosis (CF)
  • Aironite – an inhaled sodium nitrite solution to treat heart failure with preserved ejection fraction (HFpEF)

 

SPEAKER - CEO Robert Neville
 


Robert Neville has served as Savara’s CEO and Chairman since he co-founded the company in June 2008. From January 2003 to December 2004, he served as managing director of Clockwise Consulting, where he worked with the Texas Children’s Hospital and the Baylor College of Medicine to develop an ICU-based monitoring and diagnostic device. From June 2000 to December 2002, he served as Vice President of Engineering at BMC Software where he oversaw the integration and expansion of the product line based on the acquisition of his previous company. From June 1998 to May 2000, Mr. Neville served as co-founder and CEO of Evity, Inc. where he led the development of the company until its acquisition by BMC Software. Based on his work at Savara and Evity, Mr. Neville was honored as a two-time finalist for the Ernst & Young Entrepreneur of the Year award. Mr. Neville holds a post-graduate Engineering degree from the University of Natal South Africa.

Register / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

Savara Inc. SVRA $342 MM MCap
De­vel­ops in­ha­la­tion ther­a­pies for the treat­ment of pa­tients with rare pul­mo­nary con­di­tions. Three pipe­line prod­ucts: Mol­gradex, an in­haled ne­b­u­l­ized GM-CSF to treat Pul­mo­nary Alve­o­lar Pro­tei­no­sis... [more in­for­ma­tion]

Event Contact

Kelly Mueller
The Trout Group, LLC

Location of the Event and Other Places